From December 1, 2023 to February 29, 2024, the company has repurchased 30,000 shares, representing 0.03% for CAD 0.03 million. With this, the company has completed the repurchase of 1,006,394 shares, representing 1.11% for CAD 0.94 million under the buyback announced on November 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 CAD | 0.00% | -1.45% | -18.07% |
1st Jan change | Capi. | |
---|---|---|
-18.07% | 44.83M | |
+14.40% | 243M | |
-7.22% | 205M | |
+19.19% | 153M | |
+39.13% | 126M | |
-35.71% | 121M | |
+300.00% | 121M | |
+78.41% | 98.68M | |
0.00% | 87.12M | |
-59.98% | 83.6M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.